166 related articles for article (PubMed ID: 11029501)
1. Effect of segmental transcatheter arterial chemoembolization on branched chain amino acids and tyrosine ratio in patients with hepatocellular carcinoma.
Inoue H; Ito T; Siraki K; Sugimoto K; Sakai T; Oomori S; Takase K; Nakano T
Int J Oncol; 2000 Nov; 17(5):977-80. PubMed ID: 11029501
[TBL] [Abstract][Full Text] [Related]
2. Serum vascular endothelial growth factor in the course of transcatheter arterial embolization of hepatocellular carcinoma.
Suzuki H; Mori M; Kawaguchi C; Adachi M; Miura S; Ishii H
Int J Oncol; 1999 Jun; 14(6):1087-90. PubMed ID: 10339662
[TBL] [Abstract][Full Text] [Related]
3. Impact of the branched-chain amino acid to tyrosine ratio and branched-chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis.
Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T
J Gastroenterol Hepatol; 2015 Sep; 30(9):1412-9. PubMed ID: 25799910
[TBL] [Abstract][Full Text] [Related]
4. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results.
Nishimine K; Uchida H; Matsuo N; Sakaguchi H; Hirohashi S; Nishimura Y; Guo Q; Ohishi H; Nagano N; Yoshioka T
Cancer Chemother Pharmacol; 1994; 33 Suppl():S60-8. PubMed ID: 7511069
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of preoperative the branched-chain amino acid to the tyrosine ratio in hepatocellular carcinoma patients after initial hepatectomy.
Mizuguchi T; Kawamoto M; Meguro M; Nakamura Y; Harada K; Kukita K; Hirata K
J Gastrointest Surg; 2011 Aug; 15(8):1433-9. PubMed ID: 21607795
[TBL] [Abstract][Full Text] [Related]
6. [Transcatheter arterial embolization for advanced hepatocellular carcinoma--indications and limitations].
Nakamura H; Kawata S; Takamura M; Osuga K; Murakami T
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1509-15. PubMed ID: 11015994
[TBL] [Abstract][Full Text] [Related]
7. Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker.
Hiraoka A; Kato M; Marui K; Murakami T; Onishi K; Adachi T; Matsuoka J; Ueki H; Yoshino T; Tsuruta M; Aibiki T; Okudaira T; Kuroda T; Iwasaki R; Suga Y; Miyata H; Ninomiya T; Hirooka M; Abe M; Matsuura B; Michitaka K; Hiasa Y
Cancer Med; 2021 Jun; 10(11):3584-3592. PubMed ID: 33960691
[TBL] [Abstract][Full Text] [Related]
8. Branched-chain amino acids to tyrosine ratio (BTR) predicts intrahepatic distant recurrence and survival for early hepatocellular carcinoma.
Ishikawa T; Kubota T; Horigome R; Kimura N; Honda H; Iwanaga A; Seki K; Honma T; Yoshida T
Hepatogastroenterology; 2013; 60(128):2055-9. PubMed ID: 24088311
[TBL] [Abstract][Full Text] [Related]
9. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
Kanekawa T; Nagai H; Kanayama M; Sumino Y
Cancer Chemother Pharmacol; 2014 Nov; 74(5):899-909. PubMed ID: 25138286
[TBL] [Abstract][Full Text] [Related]
10. [Serial changes in serum levels of laminin and type III procollagen N-terminal peptide after transarterial embolization (TAE) in hepatocellular carcinoma].
Matsuda H
Nihon Shokakibyo Gakkai Zasshi; 1991 Feb; 88(2):153-61. PubMed ID: 1851519
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE).
Yodono H; Takekawa SD; Tarusawa K; Ikami I; Kanehira J; Saito Y; Takahashi S; Sasaki T; Nishi N; Kimura T
Cancer Chemother Pharmacol; 1994; 33 Suppl():S79-83. PubMed ID: 8137489
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
[TBL] [Abstract][Full Text] [Related]
13. Subsegmental transcatheter arterial embolization for hepatocellular carcinoma in the caudate lobe.
Terayama N; Miyayama S; Tatsu H; Yamamoto T; Toya D; Tanaka N; Mitsui T; Miura S; Fujisawa M; Kifune K; Matsui O; Takashima T
J Vasc Interv Radiol; 1998; 9(3):501-8. PubMed ID: 9618113
[TBL] [Abstract][Full Text] [Related]
14. Trans-catheter hepatic arterial injection of lipiodol soluble anti-cancer agent SMANCS and ADR suspension in lipiodol combined with arterial embolization and local hyperthermia for treatment of hepatocellular carcinoma.
Yumoto Y; Jinno K; Tokuyama K; Wada T; Kobashi H; Okamoto T; Toki H; Inatsuki S; Hara K; Moriwaki S
Int J Hyperthermia; 1991; 7(1):7-17. PubMed ID: 1711090
[TBL] [Abstract][Full Text] [Related]
15. [Transcatheter arterial embolization with SMANCS and epiADM for hepatocellular carcinoma].
Ihaya T; Ametani M; Matsusue E
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():109-15. PubMed ID: 9512698
[TBL] [Abstract][Full Text] [Related]
16. [Intra-arterial chemotherapy for the treatment of advanced hepatocellular carcinoma through implantable port (reservoir)].
Motohara T; Ozawa Z; Morita S
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2645-8. PubMed ID: 7979426
[TBL] [Abstract][Full Text] [Related]
17. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison between L-TAE with farmorubicin and L-TAE with adriamycin: preliminary results (second cooperative study). Cooperative Study Group for Liver Cancer Treatment of Japan.
Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M
Cancer Chemother Pharmacol; 1994; 33 Suppl():S97-102. PubMed ID: 7511070
[TBL] [Abstract][Full Text] [Related]
18. [Behavior of anti-cancer drug of transcatheter hepatic segmental arterial chemoembolization using lipiodol mixed with an anti-cancer drug followed by gelatin sponge assessed by Tc-99m pertechnetate].
Sakaguchi H; Yoshimura H; Nishimura Y; Iwata K; Ohishi H; Uchida H
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1725-30. PubMed ID: 2167644
[TBL] [Abstract][Full Text] [Related]
19. Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma.
Nishikawa H; Osaki Y; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Henmi S; Sakamoto A; Ishikawa T; Saito S; Kita R; Kimura T
World J Gastroenterol; 2012 Mar; 18(12):1379-84. PubMed ID: 22493552
[TBL] [Abstract][Full Text] [Related]
20. Evaluating response to nutritional therapy using the branched-chain amino acid/tyrosine ratio in patients with chronic liver disease.
Kawamura-Yasui N; Kaito M; Nakagawa N; Fujita N; Ikoma J; Gabazza EC; Watanabe S; Adachi Y
J Clin Lab Anal; 1999; 13(1):31-4. PubMed ID: 10025735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
